3 completed, 1 terminated. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 3, Terminated 1 |
Follow vaniprevir: new trials by email Literature Review of vaniprevir trials Research Report on vaniprevir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating Fine Needle Aspiration to Measure Hepatic Vaniprevir (MK-7009) Concentrations in Participants With Chronic Hepatitis C (MK-7009-048) Vaniprevir 600 mg, Peg-IFN alfa-2b, Ribavirin - Chronic Hepatitis C | Phase 1 | Completed | Merck Sharp & Dohme LLC | 31 | 2012-10-30 | 2022-08-26 |
| Pharmacokinetics of Vaniprevir (MK-7009) and Hepatitis C Virus RNA Levels After Vaniprevir Treatment (MK-7009-029) Vaniprevir - Chronic Hepatitis C Infection | Phase 1 | Terminated | Merck Sharp & Dohme LLC | 3 | 2010-01-13 | 2018-10-18 |
| A Study Investigating the Influence of Hepatic Insufficiency on the Pharmacokinetics of Vaniprevir (MK-7009-005) Vaniprevir 300 mg, Vaniprevir 200 mg - Hepatitis C | Phase 1 | Completed | Merck Sharp & Dohme LLC | 60 | 2009-07-01 | 2018-10-09 |
| Study the Safety and Effectiveness of MK7009 in Hepatitis C Infected Patients (MK-7009-004)(COMPLETED) Comparator: MK7009, Comparator: Placebo - Hepatitis C | Phase 1 | Completed | Merck Sharp & Dohme LLC | 40 | 2007-07-01 | 2015-08-25 |
Hepatitis C (3) · Hepatitis C, Chronic (1)
2009 (1)